Division of Infectious Disease and Global Epidemiology, Department of Epidemiology and Biostatistics, and Institute for Global Health Sciences, University of California San Francisco, San Francisco, California, United States of America.
Division of Infectious Diseases, School of Medicine, Washington University at St Louis, St Louis, Missouri, United States of America.
PLoS Med. 2022 Mar 15;19(3):e1003940. doi: 10.1371/journal.pmed.1003940. eCollection 2022 Mar.
Optimizing services to facilitate engagement and retention in care of people living with HIV (PLWH) on antiretroviral therapies (ARTs) is critical to decrease HIV-related morbidity and mortality and HIV transmission. We systematically reviewed the literature for the effectiveness of implementation strategies to reestablish and subsequently retain clinical contact, improve viral load suppression, and reduce mortality among patients who had been lost to follow-up (LTFU) from HIV services.
We searched 7 databases (PubMed, Cochrane, ERIC, PsycINFO, EMBASE, Web of Science, and the WHO regional databases) and 3 conference abstract archives (CROI, IAC, and IAS) to find randomized trials and observational studies published through 13 April 2020. Eligible studies included those involving children and adults who were diagnosed with HIV, had initiated ART, and were subsequently lost to care and that reported at least one review outcome (return to care, retention, viral suppression, or mortality). Data were extracted by 2 reviewers, with discrepancies resolved by a third. We characterized reengagement strategies according to how, where, and by whom tracing was conducted. We explored effects, first, among all categorized as LTFU from the HIV program (reengagement program effect) and second among those found to be alive and out of care (reengagement contact outcome). We used random-effect models for meta-analysis and conducted subgroup analyses to explore heterogeneity. Searches yielded 4,244 titles, resulting in 37 included studies (6 randomized trials and 31 observational studies). In low- and middle-income countries (LMICs) (N = 16), tracing most frequently involved identification of LTFU from the electronic medical record (EMR) and paper records followed by a combination of telephone calls and field tracing (including home visits), by a team of outreach workers within 3 months of becoming LTFU (N = 7), with few incorporating additional strategies to support reengagement beyond contact (N = 2). In high-income countries (HICs) (N = 21 studies), LTFU were similarly identified through EMR systems, at times matched with other public health records (N = 4), followed by telephone calls and letters sent by mail or email and conducted by outreach specialist teams. Home visits were less common (N = 7) than in LMICs, and additional reengagement support was similarly infrequent (N = 5). Overall, reengagement programs were able to return 39% (95% CI: 31% to 47%) of all patients who were characterized as LTFU (n = 29). Reengagement contact resulted in 58% (95% CI: 51% to 65%) return among those found to be alive and out of care (N = 17). In 9 studies that had a control condition, the return was higher among those in the reengagement intervention group than the standard of care group (RR: 1.20 (95% CI: 1.08 to 1.32, P < 0.001). There were insufficient data to generate pooled estimates of retention, viral suppression, or mortality after the return.
While the types of interventions are markedly heterogeneity, reengagement interventions increase return to care. HIV programs should consider investing in systems to better characterize LTFU to identify those who are alive and out of care, and further research on the optimum time to initiate reengagement efforts after missed visits and how to best support sustained reengagement could improve efficiency and effectiveness.
优化服务以促进接受抗逆转录病毒疗法(ART)的艾滋病毒感染者(PLWH)的参与和保持治疗,对于降低与 HIV 相关的发病率和死亡率以及 HIV 传播至关重要。我们系统地审查了文献,以了解实施策略的有效性,这些策略旨在重新建立并随后保持临床联系,提高病毒载量抑制率,并减少因失去医疗服务而随访不良(LTFU)的患者的死亡率。
我们在 7 个数据库(PubMed、Cochrane、ERIC、PsycINFO、EMBASE、Web of Science 和世界卫生组织区域数据库)和 3 个会议摘要档案(CROI、IAC 和 IAS)中进行了搜索,以寻找截至 2020 年 4 月 13 日发表的随机试验和观察性研究。合格的研究包括那些诊断为 HIV、已开始接受 ART 治疗且随后失去护理的儿童和成人,并报告了至少一项回顾性结果(返回护理、保留、病毒抑制或死亡率)。数据由两名审查员提取,通过第三名审查员解决分歧。我们根据追踪的方式、地点和人员,对重新参与策略进行了分类。我们首先探讨了所有被归类为 HIV 项目中 LTFU 的患者(重新参与计划效果)中的效果,其次探讨了那些被发现存活且未接受护理的患者(重新参与接触结果)中的效果。我们使用随机效应模型进行荟萃分析,并进行了亚组分析以探索异质性。搜索产生了 4244 个标题,最终纳入了 37 项研究(6 项随机试验和 31 项观察性研究)。在中低收入国家(LMICs)(N = 16)中,追踪最常涉及从电子病历(EMR)和纸质记录中识别 LTFU,随后是电话和现场追踪(包括家访),由一组外展工作人员在成为 LTFU 后 3 个月内进行(N = 7),很少有研究将支持重新参与的额外策略纳入(N = 2)。在高收入国家(HICs)(N = 21 项研究)中,LTFU 同样通过 EMR 系统识别,有时与其他公共卫生记录匹配(N = 4),随后通过外展专家团队进行电话和邮件或电子邮件发送的信件。家访较少见(N = 7),支持重新参与的额外支持也同样罕见(N = 5)。总体而言,重新参与计划能够使所有被归类为 LTFU 的患者中的 39%(95%CI:31%至 47%)(N = 29)返回。在那些被发现存活且未接受护理的患者中(N = 17),重新参与接触导致 58%(95%CI:51%至 65%)的返回。在 9 项具有对照条件的研究中,重新参与干预组的返回率高于标准护理组(RR:1.20(95%CI:1.08 至 1.32,P < 0.001)。没有足够的数据来生成返回后保留、病毒抑制或死亡率的汇总估计值。
尽管干预措施的类型存在明显的异质性,但重新参与干预措施可以增加返回护理的机会。HIV 项目应考虑投资建立系统,以更好地描述 LTFU,以识别那些仍存活且未接受护理的患者,并进一步研究在错过就诊后何时开始重新参与努力以及如何最好地支持持续重新参与,可以提高效率和效果。